NEW DELHI: Dengue is a mosquito-borne viral infection which causes flu-like illness, and occasionally develops into a potentially lethal complication called severe dengue which was recognised in the 1950s during dengue epidemics in the Philippines and Thailand
In a breakthrough move using the knowledge of Ayurveda, Indian scientists have developed a herbal medicine against the mosquito-borne dengue fever. As per the reports, the medicine has been developed using the alcoholic extract of Cipa derived from a species of flowering plant, Velvetleaf. The drug has proved to be resistant to four types of dengue virus.
India represents 50 percent of the global population estimated to be at risk of dengue. One of the recent estimates indicates that over 390 million dengue infections are reported every year. The prevalence of dengue estimates that 3,900 million people, in 128 countries, are at risk of infection with dengue viruses
The project was undertaken jointly by the Department of Biotechnology (DBT), under the Ministry of Science and Technology, the International Centre for Genetic Engineering and Biotechnology (IGCEB) and Ranbaxy Research Laboratory (now owned by Sun Pharma), and employed Ayurveda in devising the drug.
Using the knowledge of traditional Indian medicine, Ayurveda a systematic bioassay-guided screening approach was developed to explore the indigenous herbal bio- resource to identify plants with pan-DENV (dengue virus) inhibitory activity. The medicine was tested on rats and have got positive results.
The drug has been made from plant extracts and not chemicals, it has sought permission from both the Ministry of Ayush and also the Drug Controller of India.